UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows From Operating Activities:
Consolidated Net Income	$ 13,570	$ 15,025
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:
Provision for Credit Losses	1,186	3,222
Depreciation and Amortization	1,153	1,187
Net Accretion of Purchase Accounting Adjustments	(319)	(2,540)
Stock Based Compensation Cost	1,197	1,197
Net Amortization of Securities	634	1,160
Loss on Sales of Securities	1	1
Gain on Sale of Loans	(24)	(161)
Income on Other Equity Securities	(509)	(420)
Gain on Sale of Other Real Estate Owned, Net of Writedowns	(63)	(209)
Increase in Cash Value of Life Insurance	(578)	(524)
Deferred Income Tax Expense	1,876	1,073
Changes in Assets and Liabilities:
Decrease in Accrued Interest Receivable	590	220
Decrease in Other Assets	1,994	2,386
Increase (Decrease) in Accrued Interest Payable	(10,911)	1,421
Decrease in Other Liabilities	(2,194)	(100)
Net Cash Provided by Operating Activities	7,603	22,938
Cash Flows From Investing Activities:
Purchases of Securities Available for Sale	(24,333)	(30,236)
Proceeds from Maturities / Sales of Securities Available for Sale	7,663	6,625
Proceeds from Paydowns of Securities Available for Sale	16,287	17,258
Net Cash Paid in Acquisition	(3,279)	0
Purchases of Other Equity Securities	(713)	(11,351)
Redemption of Other Equity Securities	238	12,365
Purchase of Life Insurance	(3,000)	(2,273)
Net Increase in Loans	(94,879)	(192,107)
Net Purchases of Premises and Equipment	(389)	(2,075)
Proceeds from Sales of Other Real Estate	409	1,026
Net Increase in Federal Funds Sold	(60,158)	(88,644)
Net Cash Used in Investing Activities	(162,154)	(289,412)
Cash Flows From Financing Activities:
Net Increase (Decrease) in Deposits	323,960	(14,167)
Net Decrease in Securities Sold Under Agreements to Repurchase	(1,678)	(3,539)
Net Increase in Federal Funds Purchased	0	565
Net Advances (Repayments) on Federal Home Loan Bank Borrowings	97,008	(14,966)
Net Proceeds (Repayments) on Bank Term Funding Program	(300,000)	310,000
Payment of Dividends on Preferred Stock	(1,350)	(1,350)
Payment of Dividends on Common Stock	(3,593)	(3,042)
Net Cash Provided by Financing Activities	114,347	273,501
Net Increase (Decrease) in Cash and Cash Equivalents	(40,204)	7,027
Cash and Cash Equivalents at Beginning of Period	226,110	152,740
Cash and Cash Equivalents at End of Period	185,906	159,767
Supplemental Disclosures for Cash Flow Information:
Interest on Deposits	38,852	18,015
Interest on Borrowings	16,539	7,307
Income Tax Payments	0	0
Supplemental Schedule for Noncash Investing and Financing Activities:
Change in the Unrealized Gain (Loss) on Securities Available for Sale	(6,416)	8,002
Change in the Unrealized Gain (Loss) on Equity Securities	14	(134)
Change in Deferred Tax Effect on the Unrealized (Gain) Loss on Securities Available for Sale	1,353	(1,662)
Transfer of Loans to Other Real Estate	$ 0	$ 810